Sensus Healthcare Statistics
Total Valuation
SRTS has a market cap or net worth of $79.18 million. The enterprise value is $63.31 million.
Market Cap | 79.18M |
Enterprise Value | 63.31M |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, after market close.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SRTS has 16.45 million shares outstanding. The number of shares has increased by 0.50% in one year.
Current Share Class | 16.45M |
Shares Outstanding | 16.45M |
Shares Change (YoY) | +0.50% |
Shares Change (QoQ) | -0.60% |
Owned by Insiders (%) | 16.60% |
Owned by Institutions (%) | 25.08% |
Float | 13.72M |
Valuation Ratios
The trailing PE ratio is 44.28 and the forward PE ratio is 14.23.
PE Ratio | 44.28 |
Forward PE | 14.23 |
PS Ratio | 2.05 |
Forward PS | 1.76 |
PB Ratio | 1.54 |
P/TBV Ratio | 1.54 |
P/FCF Ratio | 17.66 |
P/OCF Ratio | 17.47 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.52, with an EV/FCF ratio of 13.68.
EV / Earnings | 35.15 |
EV / Sales | 1.60 |
EV / EBITDA | 22.52 |
EV / EBIT | 24.76 |
EV / FCF | 13.68 |
Financial Position
The company has a current ratio of 8.06, with a Debt / Equity ratio of 0.01.
Current Ratio | 8.06 |
Quick Ratio | 5.52 |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.22 |
Debt / FCF | 0.14 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 3.46% and return on invested capital (ROIC) is 3.03%.
Return on Equity (ROE) | 3.46% |
Return on Assets (ROA) | 2.72% |
Return on Invested Capital (ROIC) | 3.03% |
Return on Capital Employed (ROCE) | 4.78% |
Revenue Per Employee | $731,259 |
Profits Per Employee | $33,352 |
Employee Count | 54 |
Asset Turnover | 0.67 |
Inventory Turnover | 1.02 |
Taxes
In the past 12 months, SRTS has paid $1.66 million in taxes.
Income Tax | 1.66M |
Effective Tax Rate | 47.93% |
Stock Price Statistics
The stock price has decreased by -9.72% in the last 52 weeks. The beta is 1.32, so SRTS's price volatility has been higher than the market average.
Beta (5Y) | 1.32 |
52-Week Price Change | -9.72% |
50-Day Moving Average | 4.66 |
200-Day Moving Average | 6.02 |
Relative Strength Index (RSI) | 54.21 |
Average Volume (20 Days) | 80,098 |
Short Selling Information
The latest short interest is 898,553, so 5.46% of the outstanding shares have been sold short.
Short Interest | 898,553 |
Short Previous Month | 908,544 |
Short % of Shares Out | 5.46% |
Short % of Float | 6.55% |
Short Ratio (days to cover) | 8.88 |
Income Statement
In the last 12 months, SRTS had revenue of $39.49 million and earned $1.80 million in profits. Earnings per share was $0.11.
Revenue | 39.49M |
Gross Profit | 22.12M |
Operating Income | 2.56M |
Pretax Income | 6.45M |
Net Income | 1.80M |
EBITDA | 2.81M |
EBIT | 2.56M |
Earnings Per Share (EPS) | $0.11 |
Balance Sheet
The company has $19.07 million in cash and $654,000 in debt, giving a net cash position of $18.42 million or $1.12 per share.
Cash & Cash Equivalents | 19.07M |
Total Debt | 654,000 |
Net Cash | 18.42M |
Net Cash Per Share | $1.12 |
Equity (Book Value) | 53.03M |
Book Value Per Share | 3.22 |
Working Capital | 47.47M |
Cash Flow
In the last 12 months, operating cash flow was $4.68 million and capital expenditures -$50,000, giving a free cash flow of $4.63 million.
Operating Cash Flow | 4.68M |
Capital Expenditures | -50,000 |
Free Cash Flow | 4.63M |
FCF Per Share | $0.28 |
Margins
Gross margin is 56.02%, with operating and profit margins of 6.48% and 4.56%.
Gross Margin | 56.02% |
Operating Margin | 6.48% |
Pretax Margin | 8.76% |
Profit Margin | 4.56% |
EBITDA Margin | 7.12% |
EBIT Margin | 6.48% |
FCF Margin | 11.72% |
Dividends & Yields
SRTS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.50% |
Shareholder Yield | -0.50% |
Earnings Yield | 2.20% |
FCF Yield | 5.66% |
Analyst Forecast
The average price target for SRTS is $11.67, which is 142.37% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.67 |
Price Target Difference | 142.37% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 12.66% |
EPS Growth Forecast (5Y) | -5.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SRTS has an Altman Z-Score of 10.17 and a Piotroski F-Score of 5.
Altman Z-Score | 10.17 |
Piotroski F-Score | 5 |